What does CUSIP 00972G108 represent in this 13F holders report?

CUSIP 00972G108 is the security identifier for AKTX - AKARI THERAPEUTICS PLC - SPONSORED ADR used to aggregate holder disclosures.

How many institutions held AKTX - AKARI THERAPEUTICS PLC - SPONSORED ADR in Q4 2022?

15 institutional investors reported AKTX - AKARI THERAPEUTICS PLC - SPONSORED ADR for Q4 2022. Use the holders table for investor-level position and value details.

AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX)

CUSIP: 00972G108

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / SPONSORED ADR
Total 13F shares: 8,922,318
Total 13F value: $4,193,343
Share change: -1,191,472
SEC-reported price per share: $0.47
Number of holders: 15
Value change: -$562,753
Number of buys: 6
Number of sells: 4

Security key

00972G108

Report period

Q4 2022

Institutions

Top holders

AKTX full security history Ownership snapshot Full 13F holder table Akari Therapeutics Plc SEC filings Akari Therapeutics Plc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AKTX - AKARI THERAPEUTICS PLC - SPONSORED ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

0/13

Latest evidence

30 Sep 2022

13F Highest disclosed value: $2,703,000 13 rows are not safely comparable across share classes. Showing 1-6 of 13 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $2.7M.

0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Disclosed position value Top 5

ARMISTICE CAPITAL, LLC $2.7M

SABBY MANAGEMENT, LLC $2.58M

Omnia Family Wealth, LLC $493K

NEA Management Company, LLC $285K

Hikari Power Ltd $82K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 13 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$2,703,000 4,290,000 shares	—	30 Sep 2022
SABBY MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$2,585,000 4,103,098 shares	—	30 Sep 2022
Omnia Family Wealth, LLC	13F Company 13F	— denominator unverified	$493,000 782,372 shares	—	30 Sep 2022
NEA Management Company, LLC	13F Company 13F	— denominator unverified	$285,000 452,167 shares	—	30 Sep 2022
Hikari Power Ltd	13F Company 13F	— denominator unverified	$82,000 130,821 shares	—	30 Sep 2022
LPL Financial LLC	13F Company 13F	— denominator unverified	$77,000 122,853 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

8,922,318

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %